Reneo Pharmaceuticals | 4:持股变动声明-股东 Leonard Braden Michael
Reneo Pharmaceuticals | 3:首次持股声明-股东 Leonard Braden Michael
Reneo Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-New Enterprise Associates 15, L.P.(14.3%),NEA Partners 15, L.P.(14.3%)等
Reneo Pharmaceuticals | SC 13G:超过5%持股股东披露文件-OCTAGON CAPITAL ADVISORS LP(6.75%),OCTAGON INVESTMENTS MASTER FUND LP(6.75%)等
Reneo Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Braden M Leonard(5.1%),BML Investment Partners, L.P.(4.1%)
Reneo Pharmaceuticals | SC 13D:超过5%持股股东披露文件-TANG CAPITAL PARTNERS, LP(9.996%),TANG CAPITAL MANAGEMENT, LLC(9.996%)等
Reneo Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Novo Holdings A/S(0%)
Reneo Pharmaceuticals | 4:持股变动声明-高管 Hall Ashley
Reneo Pharmaceuticals | 4:持股变动声明-董事会执行主席 GREY MICHAEL G
Reneo Pharmaceuticals | 4:持股变动声明-股东 Novo Holdings A/S
Reneo Pharmaceuticals | 4:持股变动声明-董事 Mathers Edward T
Reneo Pharmaceuticals | 4:持股变动声明-董事 Blunt Roshawn A.
Reneo Pharmaceuticals | 4:持股变动声明-董事会执行主席 GREY MICHAEL G
Reneo Pharmaceuticals | 4:持股变动声明-董事 Hoelscher Paul W.
Reneo Pharmaceuticals | 4:持股变动声明-董事 Muralidhar Bali
Reneo Pharmaceuticals | 4:持股变动声明-董事 O'Donnell Niall
Reneo Pharmaceuticals | 4:持股变动声明-董事 Seltzer Stacey Denenberg
Reneo Pharmaceuticals | 4:持股变动声明-董事 Dube Eric M
Reneo Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-I.R.S. IDENTIFICATION NO. John P. McKearn, Ph.D.(7.53%),I.R.S. IDENTIFICATION NO. Jay Schmelter(7.53%)等
Reneo Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Novo Holdings A/S(10.2%)
暂无数据